|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0027651,
umls-concept:C0030705,
umls-concept:C0034897,
umls-concept:C0036043,
umls-concept:C0555198,
umls-concept:C0871261,
umls-concept:C1313726,
umls-concept:C1313727,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
1-2
|
|
pubmed:dateCreated |
2003-9-3
|
|
pubmed:abstractText |
This was an open-label, dose-escalation trial of intratumoral administration of IL-4 Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0167-594X
|
|
pubmed:author |
pubmed-author:AsherAnthonyA,
pubmed-author:BergerMitchelM,
pubmed-author:BruceJeffreyJ,
pubmed-author:BucholzRichardR,
pubmed-author:ChangSusanS,
pubmed-author:FloethFrankF,
pubmed-author:HallWalterW,
pubmed-author:HingoraniVijay NVN,
pubmed-author:PanHenryH,
pubmed-author:PradosMichaelM,
pubmed-author:PuriRaj KRK,
pubmed-author:RainovNikolai GNG,
pubmed-author:RandRobert WRW,
pubmed-author:RommelFrankF,
pubmed-author:WarnickRonald ERE,
pubmed-author:WeberFriedrichF,
pubmed-author:WestphalManfredM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
125-37
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12952293-Adult,
pubmed-meshheading:12952293-Aged,
pubmed-meshheading:12952293-Antibodies,
pubmed-meshheading:12952293-Astrocytoma,
pubmed-meshheading:12952293-Bacterial Toxins,
pubmed-meshheading:12952293-Cerebellar Neoplasms,
pubmed-meshheading:12952293-Dose-Response Relationship, Drug,
pubmed-meshheading:12952293-Drug Administration Schedule,
pubmed-meshheading:12952293-Exotoxins,
pubmed-meshheading:12952293-Female,
pubmed-meshheading:12952293-Glioblastoma,
pubmed-meshheading:12952293-Humans,
pubmed-meshheading:12952293-Interleukin-4,
pubmed-meshheading:12952293-Magnetic Resonance Imaging,
pubmed-meshheading:12952293-Male,
pubmed-meshheading:12952293-Middle Aged,
pubmed-meshheading:12952293-Neoplasm Recurrence, Local,
pubmed-meshheading:12952293-Safety,
pubmed-meshheading:12952293-Survival Analysis,
pubmed-meshheading:12952293-Treatment Outcome
|
|
pubmed:articleTitle |
Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma.
|
|
pubmed:affiliation |
Department of Neurological Surgery, Heinrich Heine University, Düsseldorf, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
